Pyxis Oncology, Inc. — Investor Relations & Filings
Pyxis Oncology, Inc. is a clinical-stage company focused on developing next-generation therapeutics for difficult-to-treat cancers. The company's differentiated portfolio of clinical assets is centered on two primary modalities: antibody-drug conjugates (ADCs) and immuno-oncology (IO). Its ADC technology platform is designed to deliver potent cancer-killing agents directly to tumor cells for enhanced safety and efficacy. The immuno-oncology programs utilize monoclonal antibodies (mAbs) to mobilize the body's immune system to attack cancer cells by blocking tumor defense mechanisms and overcoming immune suppression. Pyxis Oncology is advancing its product candidates as both monotherapies and in combination with other therapies to improve outcomes for patients with solid tumors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2026-05-14 | English | |
| 8-K | 2026-05-14 | English | |
| ARS - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-04-30 | English | |
| DEF 14A - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-04-30 | English | |
| 8-K/A - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-04-30 | English | |
| 4 - Pyxis Oncology, Inc. (0001782223) (Issuer) | 2026-03-25 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 45988994 | 10-Q | 2026-05-14 | English | ||
| 45977153 | 8-K | 2026-05-14 | English | ||
| 39075634 | ARS - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-04-30 | English | ||
| 39073772 | DEF 14A - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-04-30 | English | ||
| 39069707 | 8-K/A - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-04-30 | English | ||
| 33043094 | 4 - Pyxis Oncology, Inc. (0001782223) (Issuer) | 2026-03-25 | English | ||
| 33043082 | 4 - Pyxis Oncology, Inc. (0001782223) (Issuer) | 2026-03-25 | English | ||
| 33042858 | 4 - Pyxis Oncology, Inc. (0001782223) (Issuer) | 2026-03-25 | English | ||
| 33012784 | 10-K - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-03-23 | English | ||
| 33012771 | 8-K - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-03-23 | English | ||
| 31693671 | SCHEDULE 13G/A Filing | 2026-02-09 | English | ||
| 31693670 | 8-K Filing | 2026-02-06 | English | ||
| 31693678 | 4 Filing | 2026-02-05 | English | ||
|
2025
2 filings
| |||||
| 13190750 | 8-K | 2025-12-18 | English | ||
| 13190751 | Regulatory Filings 2025 | 2025-12-10 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Develops and manufactures IVD reagents and vaccines for inf…
|
603392 | CN | Manufacturing |
|
Beleave Inc.
Vertically integrated cannabis company engaged in cultivati…
|
BLEVF | CA | Manufacturing |
|
BELITE BIO, INC
Clinical-stage biopharma developing therapies for retinal a…
|
BLTE | KY | Manufacturing |
|
Benitec Biopharma Inc.
A clinical-stage biotech developing genetic medicines to si…
|
BNTC | US | Manufacturing |
|
BeOne Medicines Ltd.
Global oncology company that discovers, develops, and deliv…
|
ONC | KY | Manufacturing |
|
BEONE MEDICINES LTD.
Biopharmaceutical firm developing targeted oncology therapi…
|
688235 | CN | Manufacturing |
|
BerGenBio
Clinical-stage biopharma that developed selective AXL kinas…
|
BGBIO | NO | Manufacturing |
|
Beryl Drugs Ltd.
Manufactures IV fluids and small volume parenterals for cli…
|
524606 | IN | Manufacturing |
|
BESHOM HOLDINGS BERHAD
An investment holding company with diversified operations i…
|
— | MY | Manufacturing |
|
Besunyen Holdings Company Limited
Leading supplier of functional health teas, weight manageme…
|
926 | HK | Manufacturing |
Pyxis Oncology, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33976/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33976 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33976 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33976 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33976}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Pyxis Oncology, Inc. (id: 33976)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.